The Expression Pattern of Genes Related to Melanogenesis and Endogenous Opioids in Psoriasis
Open Access
- 2 December 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (23) , 13056
Abstract
The melanocortin system is a major regulator of stress responses in the skin and is responsible for the induction of melanin synthesis through activation of melanogenesis enzymes. The expression of both melanocortin system genes and melanogenesis enzyme genes is altered in psoriasis, and the focus here was on twelve genes related to the signal transduction between them. Additionally, five endogenous opioid system genes that are involved in cutaneous inflammation were examined. Quantitative real-time-PCR was utilized to measure mRNA expression in punch biopsies from lesional and non-lesional skin of psoriasis patients and from the skin of healthy control subjects. Most of the genes related to melanogenesis were down-regulated in patients (CREB1, MITF, LEF1, USF1, MAPK14, ICAM1, PIK3CB, RPS6KB1, KIT, and ATRN). Conversely, an up-regulation occurred in the case of opioids (PENK, PDYN, and PNOC). The suppression of genes related to melanogenesis is in agreement with the reported reduction in pigmentation signaling in psoriatic skin and potentially results from the pro-inflammatory environment. The increase in endogenous opioids can be associated with their involvement in inflammatory dysregulation in psoriasis.Keywords
Funding Information
- Eesti Teadusagentuur (PUT1465, PRG1189)
- Centre of Translational Genomics of University of Tartu (SP1GVARENG)
This publication has 57 references indexed in Scilit:
- Inflammatory Mediators Influence the Expression of Nociceptin and Its Receptor in Human Whole Blood CulturesPLOS ONE, 2013
- Melanoma genotypes and phenotypes get personalLaboratory Investigation, 2013
- Curbing Inflammation through Endogenous Pathways: Focus on Melanocortin PeptidesInternational Journal of Inflammation, 2013
- NOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune DiseasesJournal of Amino Acids, 2011
- Postinflammatory hypopigmentationClinical and Experimental Dermatology, 2011
- Regulated Proenkephalin Expression in Human Skin and Cultured Skin CellsJournal of Investigative Dermatology, 2011
- Definition of treatment goals for moderate to severe psoriasis: a European consensusArchives of Dermatological Research, 2010
- Agouti protein, mahogunin, and attractin in pheomelanogenesis and melanoblast‐like alteration of melanocytes: a cAMP‐independent pathwayPigment Cell & Melanoma Research, 2009
- The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003-2004Journal of the American Academy of Dermatology, 2009
- Neuroendocrine System of the SkinDermatology, 2005